Indonesia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Indonesia

In 2022, the Indonesian prophylactic medicaments containing insulin market decreased by -9.4% to $X for the first time since 2019, thus ending a two-year rising trend. In general, consumption, however, continues to indicate a resilient expansion. Over the period under review, the market attained the peak level at $X in 2021, and then reduced in the following year.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Indonesia

In 2022, overseas shipments of medicaments containing insulin but not antibiotics in measured doses decreased by -21% to X tons for the first time since 2015, thus ending a six-year rising trend. Overall, exports, however, enjoyed significant growth. The pace of growth appeared the most rapid in 2020 with an increase of 23,550%. The exports peaked at X tons in 2021, and then dropped notably in the following year.

In value terms, prophylactic medicaments containing insulin exports declined significantly to $X in 2022. In general, exports, however, continue to indicate a significant expansion. The most prominent rate of growth was recorded in 2020 when exports increased by 233,689%. The exports peaked at $X in 2021, and then reduced rapidly in the following year.

Exports by Country

The Philippines (X tons) was the main destination for prophylactic medicaments containing insulin exports from Indonesia, accounting for a 89% share of total exports. Moreover, prophylactic medicaments containing insulin exports to the Philippines exceeded the volume sent to the second major destination, Singapore (X kg), more than tenfold.

From 2012 to 2022, the average annual rate of growth in terms of volume to the Philippines stood at +43.7%. Exports to the other major destinations recorded the following average annual rates of exports growth: Singapore (+397.3% per year) and Vietnam (+47.6% per year).

In value terms, the Philippines ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Indonesia, comprising 98% of total exports. The second position in the ranking was taken by Singapore ($X), with a 1.2% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value to the Philippines amounted to +86.8%. Exports to the other major destinations recorded the following average annual rates of exports growth: Singapore (+633.1% per year) and Vietnam (+51.0% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, waning by -24.3% against the previous year. In general, the export price, however, saw a prominent increase. The pace of growth was the most pronounced in 2020 when the average export price increased by 889%. The export price peaked at $X per ton in 2021, and then declined notably in the following year.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the Philippines ($X per ton), while the average price for exports to Singapore ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Singapore (+47.4%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Indonesia

After two years of growth, purchases abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -8.2% to X tons in 2022. Over the period under review, imports, however, continue to indicate resilient growth. The pace of growth was the most pronounced in 2014 with an increase of 41%. Imports peaked at X tons in 2021, and then fell in the following year.

In value terms, prophylactic medicaments containing insulin imports dropped to $X in 2022. In general, total imports indicated a remarkable increase from 2012 to 2022: its value increased at an average annual rate of +6.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +3.4% against 2018 indices. The growth pace was the most rapid in 2013 with an increase of 24% against the previous year. Over the period under review, imports attained the maximum at $X in 2021, and then fell in the following year.

Imports by Country

In 2022, Brazil (X tons) constituted the largest supplier of prophylactic medicaments containing insulin to Indonesia, with a 53% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Brazil exceeded the figures recorded by the second-largest supplier, Denmark (X tons), sixfold. France (X tons) ranked third in terms of total imports with a 9.2% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Brazil totaled +33.1%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (-4.8% per year) and France (+25.2% per year).

In value terms, Brazil ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Indonesia, comprising 52% of total imports. The second position in the ranking was taken by Denmark ($X), with a 10% share of total imports. It was followed by Germany, with a 9.3% share.

From 2012 to 2022, the average annual rate of growth in terms of value from Brazil amounted to +24.9%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (-13.2% per year) and Germany (+9.4% per year).

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, declining by -2.4% against the previous year. Overall, the import price saw a abrupt setback. The growth pace was the most rapid in 2021 an increase of 4.2% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Germany ($X per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+13.9%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :